Toxicity of Chimeric Antigen Receptor T Cells and its Management

Recently, chimeric antigen receptor (CAR) T cell therapy has transformed the treatment armamentarium of relapsed/refractory B lymphoid malignancies. CAR T cells provide an excellent response rate and potential cure for these patients. However, CAR T cells also possess unique and potentially life-thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wudhikarn, Kitsada, Soh, Shui Yen, Huang, He, Perales, Miguel-Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2021
Materias:
State of the Art
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847268/
https://www.ncbi.nlm.nih.gov/pubmed/36713468
http://dx.doi.org/10.31547/bct-2021-011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847268/
https://www.ncbi.nlm.nih.gov/pubmed/36713468
http://dx.doi.org/10.31547/bct-2021-011

Ejemplares similares